More Bad News About IVC Filters From National Database Study
A nationwide observational study found that adjunctive inferior vena cava filter placement in patients undergoing catheter-directed thrombolysis does not reduce in-hospital mortality, but increases inpatient charges and length of stay. One-third of all patients undergoing catheter-directed thrombolysis receive IVC filters.
You may also be interested in...
An Indianapolis federal jury has awarded $3m to a woman who says a Cook intravenous filter broke apart within her body. This is the the third bellwether case in ongoing multi-district litigation, and the first that has ruled against Cook.
Two patients who say they were injured by vena cava filters made by Cook and Boston scientific filed suit against the manufacturers in Kentucky federal court earlier this month. The suits build on safety concerns about the filters previously circulated by FDA and researchers.
Unprecedented PRESERVE IVC Filter Study Unites Surgeons, Interventionalists, Manufacturers, And The FDA
An unprecedented clinical trial called PRESERVE is bringing together the Society of Interventional Radiology, the Society for Vascular Surgery, major manufacturers of inferior vena cava filters, and the FDA to answer questions about how the filter might best fit into modern medicine.